Selective alteration of immunocompetence with methotrexate and 5-fluorouracil
DiLorenzo, J.A.; Griswold, D.E.; Bareham, C.R.; Calabresi, P.
Cancer Research 34(1): 124-128
1974
ISSN/ISBN: 0008-5472 PMID: 4588543 Document Number: 74181
Document emailed within 1 workday
Related Documents
Shirasaka, T.; Shimamoto, Y.; Kato, T.; Fukushima, M. 1998: Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 371-384Bender, R.A.; Bleyer, W.A.; Frisby, S.A.; Oliverio, V.T. 1975: Alteration of methotrexate uptake in human leukemia cells by other agents Cancer Research 35(5): 1305-1308
Ringborg, U.; Ewert, G.; Kinnman, J.; Lundquist, P.G.; Strander, H. 1983: Methotrexate and 5-fluorouracil in head and neck cancer Seminars in Oncology 10(2 Suppl 2: 20-22
Zampino, M.G.; Lorizzo, K.; Rocca, A.; Locatelli, M.; Zorzino, L.; Manzoni, S.; Mazzetta, C.; Fazio, N.; Biffi, R.; De Braud, F. 2006: Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer Anticancer Research 26(3b): 2425-2428
Benz, C.; Tillis, T.; Tattelman, E.; Cadman, E. 1982: Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer Cancer Research 42(5): 2081-2086
Pitman, S.W.; Kowal, C.D.; Bertino, J.R. 1983: Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer Seminars in Oncology 10(2 Suppl 2: 15-19
Tattersall, M.H. 1983: Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells Seminars in Oncology 10(2 Suppl. 2): 6-14
Bruckner, H.W.; Schreiber, C.; Waxman, S. 1975: Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis Cancer Research 35(3): 801-806
Houghton, J.A.; Tice, A.J.; Houghton, P.J. 1982: The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas Molecular Pharmacology 22(3): 771-778
Tokunaga, Y.; Ryo, J.; Kitaoka, A.; Yagi, T.; Tokuka, A.; Ohsumi, K. 1999: A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin Hepato-Gastroenterology 46(27): 1736-1739
Umsawasdi, T.; Chainuvati, T.; Hitanant, S.; Nilprabhassorn, P.; Viranuvatti, V. 1976: Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma Journal of the Medical Association of Thailand 59(8): 380-383
Miller, A.B.; Klaassen, D.J.; Boyes, D.A.; Dodds, D.J.; Gerulath, A.; Kirk, M.E.; Levitt, M.; Pearson, J.G.; Wall, C. 1980: Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer Canadian Medical Association Journal 123(5): 365-371
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G. 1979: Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles Minerva Ginecologica 31(7-8): 563-568
Kinoshita, K.; Yonemura, Y.; Sawa, T.; Miyata, T.; Sakuma, H.; Matsuki, N.; Tanaka, S.; Fushida, S.; Fujimura, T.; Mok, Y.Jai.; Kim, B.Sik.; Lee, J.In.; Choi, D.Wook.; Song, Y.Jin.; Yang, D.Hyun.; Kwon, S.Joon.; Tanaka, M.; Miyazaki, I. 2003: 5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancer Hepato-Gastroenterology 50(53): 1716-1719
Mitsugi, K.; Yasutake, T.; Etoh, T.; Ishimaru, T.; Ueda, A.; Nakano, S.; Niho, Y. 1993: Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2387-2390
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S. 1980: Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems Archiv für Geschwulstforschung 50(8): 747-757
Asaumi, J. 1997: Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma In Vivo 11(2): 147-151
Schumacher, K. 2000: Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04 Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(5): 239-240